{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Prime%20Vitality%2C%20Inc.%20dba%20Prime%20Peptides","name":"Prime Vitality, Inc. dba Prime Peptides","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T15:58:45.422Z"},"count":1,"matches":[{"id":"2bee2232aacdeddb","posted_date":"2024-12-17","letter_issue_date":"2024-12-10","company_name":"Prime Vitality, Inc. dba Prime Peptides","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"Unapproved New Drugs/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/2bee2232aacdeddb"}]}